Strategic alliances with leading academic institutions, pharmaceutical companies, and regulatory bodies advancing New Approach Methodologies worldwide.
Leading research universities and institutions
Pioneering organ-on-chip technology development and translational research for drug discovery and personalized medicine applications.
Collaborative research on computational biology, AI-driven drug development, and advanced cancer modeling systems.
Joint programs in organoid development, stem cell research, and regulatory science for European market access.
Engineering excellence in microfluidics, precision medicine platforms, and advanced manufacturing for NAMs devices.
Pharmaceutical and biotechnology companies
Strategic collaboration on personalized medicine, companion diagnostics, and organ-chip toxicology screening platforms.
Joint research programs in oncology NAMs, cardiotoxicity prediction, and AI-integrated drug development pipelines.
Technology partnership for organ-chip platform development, commercialization, and regulatory qualification initiatives.
Digital twin integration, medical imaging AI, and computational modeling partnerships for precision diagnostics.
Our partnership network spans across major research hubs worldwide, enabling collaborative innovation and regulatory harmonization.
Join our global network of institutions advancing New Approach Methodologies. We offer collaboration opportunities across research, technology development, and commercialization.
Explore Partnership Opportunities